Black Book Research's rankings are exclusively determined by comprehensive user and client experience surveys. Notably, the organization does not solicit or accept any fees for vendor inclusion or listing, ensuring the integrity and impartiality of its evaluations.
Read More
Angel Ai, the revolutionary financial technology platform breaking barriers in the mortgage industry, will be prominently represented at Madison Square Garden tonight as CEO and Founder Pavan Agarwal and his right-hand man, Anthony Toro, take their seats ringside for the highly anticipated Keyshawn Davis vs. Denys Berinchyk bout, televised live on ESPN.
Read MoreWASHINGTON DC’S NEWLY-APPOINTED AME BISHOP REGINALD T. JACKSON UNITES AFRICAN-AMERICAN FAITH LEADERS FROM ACROSS THE COUNTY, LEADERS FROM THE AMERICAN CIVIL LIBERTIES UNION AND THE NAACP DEFENSE FUND, CONGREGANTS AND FEDERAL EMPLOYEES AT AME METROPOLITAN CHURCH IN WASHINGTON, DC
Read More
LiCAP Technologies Inc. and Windurance, industry-leading providers of ultracapacitor based retrofit solutions for Emergency Pitch Control, are proud to announce a partnership with UpTower, the wind industry's leading provider of installation and technical services.
Read More100% of Patients Achieved Remission Within 30 Days in Cohort 1 of the Mipletamig RAINIER Dose Optimization Trial for Frontline AML Patients, Trial Enrollment Continues
Promising Data, including a 59% Stable Disease Rate, in ALG.APV-527 Phase 1 Trial for the Treatment of Multiple Solid Tumors Makes the Case for Continued Development of First-in-Class Anti-Cancer Agent
Read More
WireDaily has released a new analysis of American Alternative Assets reviews and complaints to help consumers determine if they are reliable and make well-informed decisions.
Read MoreReports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing resizing
Reports full-year revenues of $3.2 billion, GAAP net loss of $(3.6) billion and GAAP diluted EPS of $(9.28)
Expects 2025 revenue range of $1.5 to 2.5 billion andending cash balance of approximately $6 billion
Submitted three investigational mRNA products for regulatory approval, including Moderna's next-generation COVID vaccine, RSV vaccine for high-risk adults aged 18 to 59, and flu/COVID combination vaccine
Read More
